CROI 2013: HIV Testing in Commercially Insured Pregnant Women

The Particulars: Identification of HIV infection before or during pregnancy allows for interventions that can reduce perinatal transmission risk to less than 1%. Prenatal HIV testing rates among commercially insured women with deliveries in 2009 to 2010 in the United States are unknown.

Data Breakdown: For a study, investigators analyzed records for 173,882 deliveries in 2009 and 177,930 in 2010. Claims for HIV testing in the 293 days prior to delivery were identified for 74.7% of deliveries in 2009 and 75.7% of deliveries in 2010.

Take Home Pearls: Approximately 25% of commercially insured women who delivered a baby in 2009 or 2010 appear to have had no claim for HIV testing during pregnancy. The finding highlights ongoing misses opportunities for perinatal HIV prevention.


From our CME partner, AKH Inc.

Invasive Fungal Infections (IFIs): Emerging Treatment Options and Targeted Therapies
CME Credit: 1.0 hour activity

In this activity, leading experts will review the epidemiology and prognostic implications of IFIs, as well as the new therapeutic options, and emerging research for improving outcomes in critically ill patients.

Click the link below for more information about this activity and others relating to infectious diseases.
eMedia - Primary Care




Physician's Weekly for Current Medical News, Events & Issues